Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

24 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-positive-results-from-phase-2-clinical-trials-in-glaucoma-and-diabetic-retinopathy-patients-302488857.html

06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-positive-results-from-the-completed-phase-12a-clinical-trial-of-per-001-intravitreal-implant-in-patients-with-glaucoma-302446082.html

21 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-oral-presentation-on-per-001-intravitreal-implant-for-glaucoma-at-the-association-for-research-in-vision-and-ophthalmology-arvo-meeting-302433007.html

03 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-positive-visual-structural-and-safety-data-from-a-ph12a-trial-of-per-001-in-glaucoma-patients-at-the-american-glaucoma-society-meeting-302387598.html

03 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-initiation-of-enrollment-to-the-phase-2a-clinical-trial-of-per001-intravitreal-implant-in-diabetic-retinopathy-301892514.html

20 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-initiation-of-enrollment-to-ph2a-portion-of-the-phase-12a-clinical-trial-of-per-001-intravitreal-implant-in-patients-with-glaucoma-301881971.html
ABOUT THIS PAGE